Saket Biotech Private Limited
About Saket Biotech Private Limited
Data last updated:
Saket Biotech Private Limited is a private limited company based in Nagpur, Maharashtra, India. It operates in the drug formulation and development segment of the pharmaceuticals sector. It was incorporated on 30 December 2004 and has been in existence for over 22 years.
The company is registered with the Registrar of Companies (ROC), Mumbai, under CIN U24230MH2004PTC150306.
The company has an authorised share capital of ₹1 Lakh and a paid-up capital of ₹1 Lakh. It is led by directors Vivek Rambilas Tiwari and Divya Ajay Patel.
Its last annual general meeting (AGM) was held on 30 September 2024, and its latest financial statements are for the year ended 31 March 2024. The registered office is at D – 8 Anmolclark Town, Nagpur, Maharashtra, India – 440004.
As per the financials filed for FY 2024, the company reported a revenue of ₹6.65 Lakh, a growth of 9% compared to the previous year. For the same year it recorded a net profit of ₹4.72 Lakh (net margin 70.9%) and EBITDA of ₹6.3 Lakh (EBITDA margin 94.7%). Revenue has grown at a compounded annual rate (CAGR) of 8% over three years and 8% over five years.
The current compliance status is marked as compliant by the Registrar of Companies.
Company details
Contact details
Saket Biotech Private Limited's registered office is in Nagpur, Maharashtra. Its e-mail address is in the company report.
- Email
- Registered AddressD – 8 Anmolclark Town, Nagpur, Maharashtra, India – 440004
- IndustryPharma, Drug Formulation & Development
To see the full contact details of Saket Biotech Private Limited, buy the company report.
- Company details, directors and signatories
- Historical financials and ratios
- Shareholding pattern and group structure
- Charges with holder and property details
- Legal cases, compliance and MCA filings
Financials of Saket Biotech Private Limited
FY 2024 filings availableSaket Biotech Private Limited reported revenue of ₹6.65 Lakh (up 9% YoY) for FY 2024.
Compounded Annual Growth Rate (CAGR)
Revenue has grown at a compounded annual rate (CAGR) of 8% over five years, including 9% growth in the latest year. EBITDA rose 7% in the latest year. Three- and five-year figures are compounded annual growth rates (CAGR): the steady yearly rate that links the first and the last year. All are worked out from the filed statements.
Financial Statement Summary
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profit and Loss Statement | |||||
| Revenue from Operations | |||||
| Other Income | |||||
| Total Revenue | |||||
| Cost of Materials Consumed | |||||
| Employee Benefit Expense | |||||
| Finance Costs | |||||
| Depreciation and Amortisation | |||||
| Other Expenses | |||||
| Total Expenses | |||||
| EBITDA | ₹6.3 Lakh | ||||
| Profit Before Tax | |||||
| Tax Expense | |||||
| Net Profit (PAT) | ₹4.72 Lakh | ||||
| Balance Sheet | |||||
| Share Capital | |||||
| Reserves and Surplus | |||||
| Net Worth (Total Equity) | |||||
| Long-term Borrowings | |||||
| Short-term Borrowings | |||||
| Trade Payables | |||||
| Total Liabilities | |||||
| Fixed Assets | |||||
| Investments | |||||
| Inventories | |||||
| Trade Receivables | |||||
| Cash and Bank Balance | |||||
| Total Assets | |||||
Financial Ratios
| Metrics | FY 2023-24 | FY 2022-23 | FY 2021-22 | FY 2020-21 | FY 2019-20 |
|---|---|---|---|---|---|
| Profitability | |||||
| EBITDA Margin | 94.7% | ||||
| Net Profit Margin | 70.9% | ||||
| Return on Equity (ROE) | |||||
| Return on Capital Employed (ROCE) | |||||
| Return on Assets (ROA) | |||||
| Liquidity and Debt | |||||
| Current Ratio | |||||
| Quick Ratio | |||||
| Debt-to-Equity Ratio | |||||
| Interest Coverage Ratio | |||||
| Efficiency and Growth | |||||
| Asset Turnover | |||||
| Receivable Days | |||||
| Payable Days | |||||
| Inventory Days | |||||
| Revenue Growth | |||||
| Net Profit Growth | |||||
To see the full financial statements and ratios of Saket Biotech Private Limited, buy the company report.
Board of directors of Saket Biotech Private Limited
Saket Biotech has 2 current directors and 2 former directors. Current directors are listed first, with their designation and appointment date.
| Name | Designation | Appointment Date | Tenure | Status |
|---|---|---|---|---|
| Vivek Rambilas Tiwari Also directs: Clarion Organics Limited | Director | 27 Feb 2007 | 19 Years 7 Months | Current |
| Divya Ajay Patel Also directs: Clarion Organics Limited | Director | 30 Mar 2019 | 7 Years 6 Months | Current |
Peer comparison
Saket Biotech Private Limited is compared with the 10 companies closest to it by revenue in the Pharma industry (Formulations), from the latest filed financials of each company.
| Company | Revenue | Net profit | Margin | Growth (1 yr) | Employees | Location |
|---|---|---|---|---|---|---|
| Algenix Formulations Private Limited | ₹6.82 Lakh (FY 2025) | Lucknow, Uttar Pradesh, India | ||||
| Organic Labs Private Limited | ₹6.8 Lakh (FY 2024) | 1956.0% | Chandigarh, India | |||
| Penance India Lifescience Private Limited | ₹6.68 Lakh (FY 2025) | -45.0% | Mumbai, Maharashtra, India | |||
| Uni-Med India Exports Private Limited | ₹6.67 Lakh (FY 2025) | 231.0% | Mumbai, Maharashtra, India | |||
| Lords Health Care Private Limited | ₹6.65 Lakh (FY 2025) | 28.0% | New Delhi, Delhi, India | |||
| Saket Biotech Private Limitedthis company | ₹6.65 Lakh (FY 2024) | ₹4.72 Lakh | 70.9% | 9.0% | Nagpur, Maharashtra, India | |
| Zeltron Pharmaceuticals Private Limited | ₹6.65 Lakh (FY 2021) | -78.0% | Ahmedabad, Gujarat, India | |||
| Konark Lifesciences Private Limited | ₹6.64 Lakh (FY 2025) | 5.0% | Ahmedabad, Gujarat, India | |||
| Hoshana Formulations Private Limited | ₹6.63 Lakh (FY 2025) | 14.0% | Gwalior, Madhya Pradesh, India | |||
| Soleon Life Sciences India Private Limited | ₹6.61 Lakh (FY 2024) | -62.0% | Ghaziabad, Uttar Pradesh, India | |||
| Rooters Pharma Private Limited | ₹6.6 Lakh (FY 2022) | Mumbai, Maharashtra, India |
To see the full peer comparison of Saket Biotech Private Limited, buy the company report.
Auditor
Saket Biotech Private Limited is audited by BHASIN DATAR ASSOCIATES for the financial year 2020.
| Auditor firm | Financial year | Firm registration number |
|---|---|---|
| BHASIN DATAR ASSOCIATES | FY 2020 | 115725W |
Shareholding
The shareholding of Saket Biotech Private Limited is on record for 4 financial years, the latest being FY 2020, split between promoters, domestic institutions, foreign institutions, public shareholders and others.
| Shareholder category | FY 2020 | FY 2017 | FY 2016 | FY 2015 |
|---|---|---|---|---|
| Promoters | ||||
| Domestic institutional investors (DII) | ||||
| Foreign institutional investors (FII) | ||||
| Public | ||||
| Others |
To see the full shareholding pattern of Saket Biotech Private Limited, buy the company report.
Legal cases
No court or tribunal cases involving Saket Biotech Private Limited are on our record; a case search with case numbers, parties and status is in the company report Buy the company report.
MSME payment delays
No delayed payments to MSME suppliers are on our record for Saket Biotech Private Limited; the supplier-wise MSME Form 1 check is in the company report Buy the company report.
GST
No GST registration is on our record for Saket Biotech Private Limited; the GSTIN and return-filing check is in the company report Buy the company report.
Recent activity
Saket Biotech Private Limited has 4 board changes on record since 2007: 2 appointments and 2 cessations. The latest: Divya Ajay Patel was appointed as Director on 30 Mar 2019.
Frequently asked questions
Saket Biotech is an active private limited company based in Nagpur, Maharashtra, India. The company works in drug formulation and development, within the pharma industry. It was incorporated on 30 December 2004 (22+ years old) and is registered under CIN U24230MH2004PTC150306.
Saket Biotech has 2 current directors:
- Vivek Rambilas Tiwari - Director
- Divya Ajay Patel - Director
The latest financial statements of Saket Biotech on record with the MCA are for the year ended 31 March 2024. Its last annual general meeting was held on 30 September 2024. Year-wise statements from 2015 are in the company report.
The CIN (Corporate Identification Number) of Saket Biotech is U24230MH2004PTC150306. It is issued by the Ministry of Corporate Affairs under the Companies Act, 2013, and uniquely identifies the company in India.
Saket Biotech was incorporated on 30 December 2004, making it 22+ years old. It is registered with the Registrar of Companies, Mumbai.
The peers of Saket Biotech by revenue are Algenix Formulations Private Limited, Organic Labs Private Limited, Penance India Lifescience Private Limited, Uni-Med India Exports Private Limited, Lords Health Care Private Limited and 5 more, all in the Pharma industry (Formulations).
Divya Ajay Patel was appointed as Director on 30 Mar 2019. Girishchandra Yadunandan Upadhyaya ceased to be Director on 30 Mar 2019. Madhumati Yadunandan Upadhyay ceased to be Director on 04 Jan 2017. Saket Biotech has 4 board changes on record in total.
The registered office of Saket Biotech is at D – 8 Anmolclark Town, Nagpur, Maharashtra, India – 440004.
Saket Biotech operates in the pharma industry, in the drug formulation and development segment.
The compliance status of Saket Biotech is compliant as of 30 July 2026. The company is actively filing with the Registrar of Companies.
Saket Biotech can be reached at its registered office: D – 8 Anmolclark Town, Nagpur, Maharashtra, India – 440004.